Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,74 USD | -7,45% | +0,58% | -22,67% |
21/03 | VOR BIOPHARMA INC. : Stifel Nicolaus herhaalt koopadvies voor het aandeel | ZM |
21/03 | VOR BIOPHARMA INC. : Oppenheimer geeft koopadvies | ZM |
Vakgebied
Aantal werknemers: 168
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 01-05-20 |
Chief Tech/Sci/R&D Officer | 51 | 01-10-19 | |
Eyal Attar
CTO | Chief Tech/Sci/R&D Officer | 53 | 12-10-22 |
Sarah Spencer
IRC | Investor Relations Contact | - | - |
Tania Philipp
HRO | Human Resources Officer | 52 | 01-12-19 |
John C. King
PRN | Corporate Officer/Principal | 49 | 01-08-20 |
General Counsel | 76 | 01-04-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 30-07-20 |
Matt Patterson
CHM | Chairman | 52 | 20-10-20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Bill Lundberg
BRD | Director/Board Member | 60 | 31-07-19 |
Daniella Beckman
BRD | Director/Board Member | 45 | 16-07-20 |
Joshua Resnick
BRD | Director/Board Member | 49 | 01-02-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 68 226 070 | 67 362 527 ( 98,73 %) | 10 299 ( 0,0151 %) | 98,73 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,67% | 128 mln. | |
+4,09% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+9,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+9,32% | 25,28 mld. | |
-24,87% | 18,47 mld. | |
+29,70% | 12,59 mld. | |
+1,28% | 12,33 mld. | |
+7,78% | 11,03 mld. |